Decision Rules

Stage	Category	Field	Operator	Value	Outcome	Explanation	Priority
1	HARD_NO_GO	modality	IN_LIST	biologics, gene_therapy, gene therapy, cell_therapy, cell therapy, adc, antibody drug conjugate	NO_GO	Biologics, gene/cell therapy, and ADCs are outside CDMO capabilities	100
1	HARD_NO_GO	scale	IN_LIST	commercial_dp, commercial drug product, commercial scale	NO_GO	Commercial drug product volumes exceed facility capacity	90
1	HARD_NO_GO	modality	CONTAINS	hpapi category 4	NO_GO	HPAPI Category 4/5 compounds require specialized containment beyond current capabilities	85
1	CONDITIONAL	timeline	CONTAINS	urgent, asap, rush, immediate	CONDITIONAL	Aggressive timeline may not be achievable with standard scheduling	50
1	GO	devStage	IN_LIST	phase 1, phase 2, phase 3, clinical, preclinical	GO	Clinical-stage work is core CDMO capability	30
1	GO	modality	IN_LIST	small molecule, peptide, oligonucleotide	GO	Modality within standard CDMO capabilities	20
2	CONDITIONAL	scale	CONTAINS	100 kg, 200 kg, 500 kg	CONDITIONAL	Scale near upper capacity limits, requires capacity review	60
2	CONDITIONAL	gmpIntent	EQUALS	UNCLEAR	CONDITIONAL	GMP requirement not confirmed - impacts timeline and cost significantly	40